Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)-Reference-Cited by-同舟云学术

Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)

Published:2023-12 Issue: Volume: Page:
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Thomson David J.,Slevin Nick J.,Baines Helen,Betts Guy^ORCID,Bolton Steve,Evans Mererid,Garcez Kate,Irlam Joely,Lee Lip,Melillo Nicola^ORCID,Mistry Hitesh,More Elisabet,Nutting Christopher,Price James M.,Schipani Stefano,Sen Mehmet,Yang Huiqi,West Catharine M.,Aynsley Eleanor,Banner Russel,Barnett Gill,Cardale Kate,Christian Judith,Fresco Lydia,Grant Warren,Hartley Andrew,Lester James,McCloskey Paula,Prestwich Robin,Shenoy Aditya,Thiagarajan Sridhar,Wood Katie

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference45 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Descriptive epidemiology of the head and neck cancers in old patients;Gatta;Front Oncol,2023

3. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data;Pignon;Lancet,2000

4. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

5. Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck;Bonner;New Engl J Med,2006